Benchling, which makes cloud-based software to manage biotech R&D, raises a $100M Series F at a $6.1B valuation; Benchling was last valued at $4B in April (Michelle F Davis/Bloomberg)
Benchling, which makes cloud-based software to manage biotech R&D, raises a $100M Series F at a $6.1B valuation; Benchling was last valued at $4B in April — - New investor Franklin Templeton leads round with Altimeter — Companies using firm's software include Regeneron, Eli Lilly
from Techmeme https://ift.tt/3HAC5kP
No comments
Post a Comment